PTCT logo

PTC Therapeutics (PTCT)

Profile

Full Name

PTC Therapeutics, Inc.

Ticker Symbol

PTCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 20, 2013

Indexes

Not included

Website

http://www.ptcbio.com

Employees

939

Key Details

Price

$47.39(+2.11%)

Market cap

$3.74B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$806.78M(-13.97% YoY)

Annual EPS

-$4.73(+43.49% YoY)

PE ratio

-

Next earnings date

Apr 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$47.39
PTCT price is $47.39

30-Day Relative Volume

0.90
PTCT 30-day relative volume is 0.90

Price Performance

Price Most recent change

+2.11%
PTCT price was up +2.11% on Apr 17, 2025

Price YTD change

+4.98%
PTCT price is up +4.98% since January 1st

Price 1-year change

+88.35%
PTCT price is up +88.35% year-on-year

Price 3-year change

+6.49%
PTCT price is up +6.49% over the past 3 years

Price Range

Price All-time high

$78.72
PTCT price is currently -39.80% below its historical high of $78.72

Price 3-year low

$17.53
PTCT price is currently +170.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.74B
PTCT market capitalization is $3.74 billion

Market cap 3-year change

+17.7%
PTCT market capitalization is up +17.7% over the past 3 years

Market cap All-time high

$4.80B
PTCT market capitalization is currently -22.21% below its historical high of $4.80 billion

Market cap sector rank

87.98%
PTCT market capitalization is higher than 87.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.89%
PTCT shares outstanding is up +2.89% year-on-year

Shares Outstanding 3-Year Change

+10.52%
PTCT shares outstanding is up +10.52% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.06
PTCT beta is 1.06

200-day SMA

$42.12
PTCT price is currently +12.51% above its 200-day simple moving average

50-day SMA

$50.51
PTCT price is currently -6.19% below its 50-day simple moving average

RSI

48.53
PTCT 14-day relative strength index is 48.53

Volume

0.90
PTCT 30-day relative volume is 0.90

ATR

$3.45
PTCT average true range is $3.45

10-day Historical Volatility

89.66%
PTCT 10-day historical volatility is 89.66%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$806.78M
PTCT annual revenue is $806.78 million

Revenue Analysts estimate

$886.24M
PTCT annual revenue is currently -8.97% lower than the consensus analysts' forecast

Revenue 1-year change

-13.97%
PTCT annual revenue is down -13.97% year-on-year

Revenue Sector rank

79.15%
PTCT annual revenue is higher than 79.15% of companies in Healthcare sector

EPS

EPS

-$4.73
PTCT annual earnings per share is -$4.73

EPS Analysts estimate

-$3.36
PTCT annual earnings per share is currently +40.64% higher than the consensus analysts' forecast

EPS 1-year change

+43.49%
PTCT annual earnings per share is up +43.49% year-on-year

EPS Sector rank

20.22%
PTCT annual earnings per share is higher than 20.22% of companies in Healthcare sector

Profit

Gross profit

$749.38M
PTCT annual gross profit is $749.38 million

Gross margin

92.89%
PTCT annual gross profit margin is 92.89%

Operating profit

-$146.75M
PTCT annual operating income is -$146.75 million

Operating margin

-18.19%
PTCT annual operating profit margin is -18.19%

Net income

-$363.30M
PTCT annual net profit is -$363.30 million

Net margin

-45.03%
PTCT annual net profit margin is -45.03%

Expenses

Total expenses

$953.53M
PTCT annual total expenses is $953.53 million

Operating expenses

$896.13M
PTCT annual total operating expenses is $896.13 million

Cost of goods sold

$57.40M
PTCT annual cost of goods sold is $57.40 million

Selling, general & administrative expenses

$300.91M
PTCT annual SGA is $300.91 million

Depreciation and amortization

$75.66M
PTCT annual depreciation & amortization is $75.66 million

Interest expense

$166.99M
PTCT annual interest expense is $166.99 million

Income tax

$176.00K
PTCT annual income tax is $176.00 thousand

EBIT & EBITDA

EBIT

-$196.13M
PTCT annual earnings before interest & taxes is -$196.13 million

EBITDA

-$120.46M
PTCT annual EBITDA is -$120.46 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.71B
PTCT annual total assets is $1.71 billion

Non current assets

$339.49M
PTCT annual long term assets is $339.49 million

Current assets

$1.37B
PTCT annual total current assets is $1.37 billion

Cash and cash equivalents

$779.71M
PTCT annual cash & cash equivalents is $779.71 million

Accounts receivable

$158.55M
PTCT annual accounts receivable is $158.55 million

Inventory

$23.19M
PTCT annual inventory is $23.19 million

Liabilities

Total liabilities

$2.80B
PTCT annual total liabilities is $2.80 billion

Long term liabilities

$2.22B
PTCT annual total long term liabilities is $2.22 billion

Current liabilities

$580.98M
PTCT annual total current liabilities is $580.98 million

Accounts payable

$17.27M
PTCT annual accounts payable is $17.27 million

Debt

Total debt

$2.47B
PTCT annual total debt is $2.47 billion

Total debt 1-year change

+10.85%
PTCT annual total debt is up +10.85% year-on-year

Long term debt

$2.20B
PTCT annual long term debt is $2.20 billion

Short term debt

$271.18M
PTCT annual short term debt is $271.18 million

Equity & Capital

Shareholders equity

-$1.10B
PTCT annual stockholders equity is -$1.10 billion

Book value

-$1.10B
PTCT annual book value is -$1.10 billion

Retained earnings

-$3.65B
PTCT annual retained earnings is -$3.65 billion

Working capital

$784.55M
PTCT annual working capital is $784.55 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$107.69M
PTCT annual cash flow from operations is -$107.69 million

Cash from operations 1-year change

+32.02%
PTCT annual cash flow from operations is up +32.02% year-on-year

Cash from investing

$44.18M
PTCT annual cash flow from investing activities is $44.18 million

Cash from investing 1-year change

+125%
PTCT annual cash flow from investing activities is up +125% year-on-year

Cash from financing

$255.87M
PTCT annual cash flow from financing activities is $255.87 million

Cash from financing 1-year change

-60.42%
PTCT annual cash flow from financing activities is down -60.42% year-on-year

CAPEX

CAPEX

$74.25M
PTCT annual capital expenditures is $74.25 million

CAPEX 1-year change

-38.44%
PTCT annual capital expenditures is down -38.44% year-on-year

Free Cash Flow

Free cash flow

-$181.94M
PTCT annual free cash flow is -$181.94 million

Free cash flow 1-year change

+34.8%
PTCT annual free cash flow is up +34.8% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

92.89%
PTCT annual gross profit margin is 92.89%

Operating margin

-18.19%
PTCT annual operating profit margin is -18.19%

Net margin

-45.03%
PTCT annual net profit margin is -45.03%

ROA & ROE

ROA

-20.18%
PTCT annual return on assets is -20.18%

ROE

33.08%
PTCT annual return on equity is 33.08%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PTCT price to earnings ratio value is unknown

PE ratio Sector rank

-
PTCT price to earnings ratio is unknown

PB Ratio

PB ratio

-3.40
PTCT price to book ratio is -3.40

PB ratio Sector rank

5.11%
PTCT price to book ratio is higher than 5.11% of companies in Healthcare sector

PS Ratio

PS ratio

4.63
PTCT price to sales ratio is 4.63

PS ratio Sector rank

65.08%
PTCT price to sales ratio is higher than 65.08% of companies in Healthcare sector

Enterprise value

Enterprise value

$5.43B
PTCT enterprise value is $5.43 billion

Enterprise value Sector rank

88.68%
PTCT enterprise value is higher than 88.68% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-45.07
PTCT EV/EBITDA is -45.07

EV/EBITDA Sector rank

3.13%
PTCT EV/EBITDA is higher than 3.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.35
PTCT annual current ratio is 2.35

Quick ratio

2.31
PTCT annual quick ratio is 2.31

Leverage

Debt to equity

-2.16
PTCT annual debt to equity ratio is -2.16

Interest coverage ratio

-1.17
PTCT annual interest coverage ratio is -1.17

Risk & Stability

Piotroski F-Score

3
PTCT piotroski f-score is 3

Altman Z-Score

-1.55
PTCT altman z-score is -1.55

Analyst ratings

Recent major analysts updates

Mar 31, 25 JP Morgan
Overweight
Mar 14, 25 JP Morgan
Overweight
Mar 11, 25 B of A Securities
Neutral
Mar 7, 25 Scotiabank
Sector Perform
Feb 28, 25 JP Morgan
Overweight
Feb 18, 25 RBC Capital
Outperform
Feb 12, 25 Citigroup
Sell
Feb 3, 25 Cantor Fitzgerald
Overweight
Jan 15, 25 Cantor Fitzgerald
Overweight
Dec 13, 24 Morgan Stanley
Overweight

Institutional Ownership

Similar stocks

RDNT logo
RadNet (RDNT)
RYTM logo
Rhythm Pharmaceuticals (RYTM)
ITGR logo
Integer Holdings (ITGR)
PCVX logo
Vaxcyte (PCVX)
ALHC logo
Alignment Healthcare (ALHC)
PBH logo
Prestige Consumer Healthcare (PBH)
PRGO logo
Perrigo (PRGO)
ACLX logo
Arcellx (ACLX)
ICUI logo
ICU Medical (ICUI)
  • What is the ticker symbol for PTC Therapeutics?
  • Does PTC Therapeutics pay dividends?
  • What sector is PTC Therapeutics in?
  • What industry is PTC Therapeutics in?
  • What country is PTC Therapeutics based in?
  • When did PTC Therapeutics go public?
  • Is PTC Therapeutics in the S&P 500?
  • Is PTC Therapeutics in the NASDAQ 100?
  • Is PTC Therapeutics in the Dow Jones?
  • When was PTC Therapeutics's last earnings report?
  • When does PTC Therapeutics report earnings?
  • Should I buy PTC Therapeutics stock now?

What is the ticker symbol for PTC Therapeutics?

The ticker symbol for PTC Therapeutics is NASDAQ:PTCT

Does PTC Therapeutics pay dividends?

No, PTC Therapeutics does not pay dividends

What sector is PTC Therapeutics in?

PTC Therapeutics is in the Healthcare sector

What industry is PTC Therapeutics in?

PTC Therapeutics is in the Biotechnology industry

What country is PTC Therapeutics based in?

PTC Therapeutics is headquartered in United States

When did PTC Therapeutics go public?

PTC Therapeutics's initial public offering (IPO) was on June 20, 2013

Is PTC Therapeutics in the S&P 500?

No, PTC Therapeutics is not included in the S&P 500 index

Is PTC Therapeutics in the NASDAQ 100?

No, PTC Therapeutics is not included in the NASDAQ 100 index

Is PTC Therapeutics in the Dow Jones?

No, PTC Therapeutics is not included in the Dow Jones index

When was PTC Therapeutics's last earnings report?

PTC Therapeutics's most recent earnings report was on Feb 27, 2025

When does PTC Therapeutics report earnings?

The next expected earnings date for PTC Therapeutics is Apr 25, 2025

Should I buy PTC Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page